234096-34-5 Usage
Description
Cefovecin, also known by its brand name Convenia, is a third-generation cephalosporin antibiotic that is primarily used for veterinary purposes. It is a long-acting injectable antibiotic, making it particularly useful in cases where oral administration of medication is challenging. Cefovecin is characterized by its extended-spectrum activity against various bacterial infections, although it may not exhibit the same level of activity as other injectable third-generation cephalosporins like cefotaxime.
Uses
Used in Veterinary Medicine:
Cefovecin is used as an antibiotic for the treatment of bacterial infections in dogs and cats. It is particularly effective against skin conditions, periodontal disease, and urinary tract infections. The long-acting nature of Cefovecin makes it a suitable choice for outpatient treatment of parvovirus and other bacterial infections where oral medication administration may be difficult.
Used in Skin Infections Treatment:
Cefovecin is used as a therapeutic agent for treating skin infections in dogs and cats. Its broad-spectrum activity allows it to target a wide range of bacteria responsible for skin conditions, providing relief and promoting healing.
Used in Periodontal Disease Treatment:
Cefovecin is utilized as an antibiotic in the treatment of periodontal disease in dogs and cats. It helps to combat the bacterial infections that contribute to gum inflammation, tooth decay, and other oral health issues.
Used in Urinary Tract Infections Treatment:
Cefovecin is employed as a treatment option for urinary tract infections in dogs and cats. Its effectiveness against various bacteria that cause these infections makes it a valuable tool in managing and treating such conditions.
Used in Outpatient Treatment for Parvovirus and Other Bacterial Infections:
Cefovecin is used as a part of outpatient treatment for parvovirus and other bacterial infections in dogs and cats. Its long-acting injectable form allows for convenient administration and effective treatment, even when oral medication is not feasible.
Indications
Cefovecin is approved for use in dogs and cats. It is approved in the US for skin and soft tissue infections but also has been used to treat urinary tract infections, for which it is approved in some countries. The efficacy of cefovecin for treating infections in other sites, such as the respiratory tract, bone, and central nervous system, has not been established. Experience is limited to administration of cefovecin in dogs and Cats; the use in other species, such as horses, large animals, birds, and reptiles, is not recommended until specific dosing recommendations are published.
Mode of action
Cephalosporin antibiotic. Action is similar to other beta-lactam antibiotics, which inhibit synthesis of bacterial cell wall leading to cell death. Cephalosporins are divided into first- , second , third-, and fourth -generation drugs depending on spectrum of activity. Cefovecin is considered a third -generation cephalosporin but may not have the same activity as other injectable third- generation cephalosporins, such as cefotaxime. Cefovecin has good activity against streptococci, Staplylococcus species, and gram-negative bacilli. MIC values are lower for cefovecin than first-generation cephalosporins. Some Enterobacterinceae can devlop resistance. It is not active against Psendomonas aernginosa. Methicillin resistant staphylococci are considered resistant to cefovecin. Activity against anaerobic bacteria is unpredictable. Cefovecin is greater than 99% protein bound in cats and greater than 98% in dogs, which is partly responsible for the long duration. The terminal half-life is approximately 7 days in cats and 5 days in dogs, and effective concentrations can be maintained in the tissue fluid of these species for 14 days.
Check Digit Verification of cas no
The CAS Registry Mumber 234096-34-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,4,0,9 and 6 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 234096-34:
(8*2)+(7*3)+(6*4)+(5*0)+(4*9)+(3*6)+(2*3)+(1*4)=125
125 % 10 = 5
So 234096-34-5 is a valid CAS Registry Number.
InChI:InChI=1/C17H19N5O6S2/c1-27-21-10(8-6-30-17(18)19-8)13(23)20-11-14(24)22-12(16(25)26)7(5-29-15(11)22)9-3-2-4-28-9/h6,9,11,15H,2-5H2,1H3,(H2,18,19)(H,20,23)(H,25,26)/b21-10-/t9-,11+,15?/m0/s1
